These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease. Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134 [TBL] [Abstract][Full Text] [Related]
24. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783 [TBL] [Abstract][Full Text] [Related]
26. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases. Denko CW; Malemud CJ Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221 [TBL] [Abstract][Full Text] [Related]
27. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. Argente J; Caballo N; Barrios V; Pozo J; Muñoz MT; Chowen JA; Hernández M J Clin Endocrinol Metab; 1997 Jul; 82(7):2076-83. PubMed ID: 9215275 [TBL] [Abstract][Full Text] [Related]
28. Individual igf-I responsiveness to a fixed regimen of low-dose growth hormone replacement is increased with less variability in obese compared to non-obese adults with severe growth hormone deficiency. Yuen KC; Cook DM; Rumbaugh EE; Cook MB; Dunger DB Horm Res; 2006; 65(1):6-13. PubMed ID: 16340214 [TBL] [Abstract][Full Text] [Related]
29. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640 [TBL] [Abstract][Full Text] [Related]
30. [Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters]. Pavelková A; Pavelka K Vnitr Lek; 2006 May; 52(5):477-80. PubMed ID: 16771094 [TBL] [Abstract][Full Text] [Related]
31. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404 [TBL] [Abstract][Full Text] [Related]
32. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221 [TBL] [Abstract][Full Text] [Related]
33. Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents. Eliakim A; Nemet D; Zaldivar F; McMurray RG; Culler FL; Galassetti P; Cooper DM J Appl Physiol (1985); 2006 May; 100(5):1630-7. PubMed ID: 16373448 [TBL] [Abstract][Full Text] [Related]
34. IGF-1 levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency. Maccario M; Grottoli S; Aimaretti G; Gianotti L; Endrio Oleandri S; Procopio M; Savio P; Tassone F; Ramunni J; Camanni F; Ghigo E Minerva Endocrinol; 1999 Jun; 24(2):57-61. PubMed ID: 10941424 [TBL] [Abstract][Full Text] [Related]
35. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562 [TBL] [Abstract][Full Text] [Related]
36. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery. Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378 [TBL] [Abstract][Full Text] [Related]
37. Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Zincarelli C; Iervolino S; Di Minno MN; Miniero E; Rengo C; Di Gioia L; Vitale D; Nicolino A; Furgi G; Pappone N Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1765-9. PubMed ID: 22623449 [TBL] [Abstract][Full Text] [Related]
38. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262 [TBL] [Abstract][Full Text] [Related]
39. The role of growth factors in degenerative joint disorders. Moskowitz RW; Boja B; Denko CW J Rheumatol Suppl; 1991 Feb; 27():147-8. PubMed ID: 2027117 [TBL] [Abstract][Full Text] [Related]